Caricamento...
PSA, PSA derivatives, proPSA and prostate health index in the diagnosis of prostate cancer
Currently, prostate- specific antigen (PSA) is the most common oncological marker used for prostate cancer screening. However, high levels of PSA in benign prostatic hyperplasia and prostatitis decrease the specificity of PSA as a cancer marker. To increase the specificity of PSA, PSA derivatives an...
Salvato in:
| Pubblicato in: | Turk J Urol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Turkish Association of Urology
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4548380/ https://ncbi.nlm.nih.gov/pubmed/26328156 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/tud.2014.94547 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|